|
Real-time Estimate
Cboe Europe
16:37:06 17/11/2026 +04
|
5-day change | 1st Jan Change | ||
| 1.736 SEK | -1.98% |
|
-3.07% | -63.85% |
| 11-09 | Oncopeptides Wins EU Approval to Expand Pepaxti Label for Third-line Treatment | MT |
| 11-09 | Oncopeptides receives EU approval for expanded use of Pepaxti | FW |
Chart: Technical Analysis
Nasdaq StockholmSEK
| Markets | Quality | ||
|---|---|---|---|
Nasdaq Stockholm
| ONCO | Delayed | |
| ONCOs | Real-time | ||
| OND | Delayed | ||
| 0RN4 | Delayed | ||
| 0RN4 | Real-time | ||
| OND | Delayed | ||
| OND | Real-time |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Neutral | Neutral |
| Resistance | 2.304 | 2.964 | 4.875 |
| Spread/Res. | -24.61% | -41.40% | -64.37% |
| Spread/Supp. | +11.27% | +11.27% | +37.10% |
| Support | 1.561 | 1.561 | 1.267 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- ONCO Stock
- Charts Oncopeptides AB
Select your edition
All financial news and data tailored to specific country editions
















